Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 128 entries
Sorted by: Best Match Show Resources per page
Editorial: HLA-G-Mediated Immune Tolerance: Past and New Outlooks.

Frontiers in immunology

Gregori S.
PMID: 28082987
Front Immunol. 2016 Dec 27;7:653. doi: 10.3389/fimmu.2016.00653. eCollection 2016.

No abstract available.

Cite
Gregori S. Editorial: HLA-G-Mediated Immune Tolerance: Past and New Outlooks. Front Immunol. 2016;7:653doi: 10.3389/fimmu.2016.00653.
Gregori, S. (2016). Editorial: HLA-G-Mediated Immune Tolerance: Past and New Outlooks. Frontiers in immunology, 7653. https://doi.org/10.3389/fimmu.2016.00653
Gregori, Silvia. "Editorial: HLA-G-Mediated Immune Tolerance: Past and New Outlooks." Frontiers in immunology vol. 7 (2016): 653. doi: https://doi.org/10.3389/fimmu.2016.00653
Gregori S. Editorial: HLA-G-Mediated Immune Tolerance: Past and New Outlooks. Front Immunol. 2016 Dec 27;7:653. doi: 10.3389/fimmu.2016.00653. eCollection 2016. PMID: 28082987; PMCID: PMC5186788.
Copy Download .nbib Format: NLM
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma.

OncoTargets and therapy

Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR.
PMID: 24966688
Onco Targets Ther. 2014 Jun 13;7:1061-70. doi: 10.2147/OTT.S61442. eCollection 2014.

BACKGROUND: Immunotherapy for human hepatocellular cancer (HCC) is slowly making progress towards treating these fatal cancers. The identification of new antigens can improve this approach. We describe a possible new antigen, hepatocellular carcinoma-associated antigen-519/targeting protein for Xklp-2 (HCA519/TPX2), for...

Cite
Aref AM, Hoa NT, Ge L, et al. HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma. Onco Targets Ther. 2014;7:1061-70doi: 10.2147/OTT.S61442.
Aref, A. M., Hoa, N. T., Ge, L., Agrawal, A., Dacosta-Iyer, M., Lambrecht, N., Ouyang, Y., Cornforth, A. N., & Jadus, M. R. (2014). HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma. OncoTargets and therapy, 71061-70. https://doi.org/10.2147/OTT.S61442
Aref, Ahmed M, et al. "HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma." OncoTargets and therapy vol. 7 (2014): 1061-70. doi: https://doi.org/10.2147/OTT.S61442
Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR. HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma. Onco Targets Ther. 2014 Jun 13;7:1061-70. doi: 10.2147/OTT.S61442. eCollection 2014. PMID: 24966688; PMCID: PMC4063820.
Copy Download .nbib Format: NLM
Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia.

Leukemia & lymphoma

Gamliel H, Gurfel D, Wu SH, Salzberg S, Golomb HM.
PMID: 27456740
Leuk Lymphoma. 1990;2(3):235-42. doi: 10.3109/10428199009053529.

Little is known about the mechanism(s) by which alpha-interferon (aIFN), when used as a biotherapeutic agent, suppresses the malignant cells and restores the normal phenotype of cells in patients with hairy cell leukemia (HCL). In previous studies using scanning...

Cite
Gamliel H, Gurfel D, Wu SH, et al. Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia. Leuk Lymphoma. 1990;2(3):235-42doi: 10.3109/10428199009053529.
Gamliel, H., Gurfel, D., Wu, S. H., Salzberg, S., & Golomb, H. M. (1990). Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia. Leukemia & lymphoma, 2(3), 235-42. https://doi.org/10.3109/10428199009053529
Gamliel, H, et al. "Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia." Leukemia & lymphoma vol. 2,3 (1990): 235-42. doi: https://doi.org/10.3109/10428199009053529
Gamliel H, Gurfel D, Wu SH, Salzberg S, Golomb HM. Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia. Leuk Lymphoma. 1990;2(3):235-42. doi: 10.3109/10428199009053529. PMID: 27456740.
Copy Download .nbib Format: NLM
Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.

Asia Pacific allergy

Thong BY.
PMID: 24260726
Asia Pac Allergy. 2013 Oct;3(4):215-23. doi: 10.5415/apallergy.2013.3.4.215. Epub 2013 Oct 31.

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCAR) to drugs which are associated with significant morbidity and mortality. High risk drugs in Asia are similar to those reported worldwide. Human leukocyte antigen (HLA)-related...

Cite
Thong BY. Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pac Allergy. 2013;3(4):215-23doi: 10.5415/apallergy.2013.3.4.215.
Thong, B. Y. (2013). Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pacific allergy, 3(4), 215-23. https://doi.org/10.5415/apallergy.2013.3.4.215
Thong, Bernard Yu-Hor. "Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective." Asia Pacific allergy vol. 3,4 (2013): 215-23. doi: https://doi.org/10.5415/apallergy.2013.3.4.215
Thong BY. Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pac Allergy. 2013 Oct;3(4):215-23. doi: 10.5415/apallergy.2013.3.4.215. Epub 2013 Oct 31. PMID: 24260726; PMCID: PMC3826606.
Copy Download .nbib Format: NLM
HLA Antigens in Omani Psoriasis Vulgaris Patients.

Oman medical journal

Al-Mamari F, Al-Shirawi A, Banodkar D, Al-Hashmi S, Al-Yahyaae F, Varghese M, Raeburn J.
PMID: 22303505
Oman Med J. 2009 Jan;24(1):27-9. doi: 10.5001/omj.2009.7.

OBJECTIVES: To determine the frequency of different HLA-antigens in patients with plaque psoriasis in the Omani Arab population.METHODS: Fifty four Omani patients clinically diagnosed with plaque psoriasis attending the dermatology outpatient clinic in Al-Nahdah Hospital (the tertiary dermatology centre...

Cite
Al-Mamari F, Al-Shirawi A, Banodkar D, et al. HLA Antigens in Omani Psoriasis Vulgaris Patients. Oman Med J. 2009;24(1):27-9doi: 10.5001/omj.2009.7.
Al-Mamari, F., Al-Shirawi, A., Banodkar, D., Al-Hashmi, S., Al-Yahyaae, F., Varghese, M., & Raeburn, J. (2009). HLA Antigens in Omani Psoriasis Vulgaris Patients. Oman medical journal, 24(1), 27-9. https://doi.org/10.5001/omj.2009.7
Al-Mamari, Fatma, et al. "HLA Antigens in Omani Psoriasis Vulgaris Patients." Oman medical journal vol. 24,1 (2009): 27-9. doi: https://doi.org/10.5001/omj.2009.7
Al-Mamari F, Al-Shirawi A, Banodkar D, Al-Hashmi S, Al-Yahyaae F, Varghese M, Raeburn J. HLA Antigens in Omani Psoriasis Vulgaris Patients. Oman Med J. 2009 Jan;24(1):27-9. doi: 10.5001/omj.2009.7. PMID: 22303505; PMCID: PMC3269622.
Copy Download .nbib Format: NLM
Origin of lymph node-derived lymphocytes in human hepatic allografts.

Clinical transplants

Fung JJ, Zeevi A, Demetris AJ, Starzl TE, Markus B, Chen K, Marrarri M, Duquesnoy RJ.
PMID: 23258949
Clin Transpl. 1989;3:316-324.

Hepatic allograft-derived lymph nodes were examined in the post-transplant period on order to determine the origin of lymphocytes and structural elements of the lymph node. Histologic assessment and immunohistochemical studies verified that T-cell infiltration of donor lymph nodes by...

Cite
Fung JJ, Zeevi A, Demetris AJ, et al. Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl. 1989;3:316-324
Fung, J. J., Zeevi, A., Demetris, A. J., Starzl, T. E., Markus, B., Chen, K., Marrarri, M., & Duquesnoy, R. J. (1989). Origin of lymph node-derived lymphocytes in human hepatic allografts. Clinical transplants, 3316-324.
Fung, John J, et al. "Origin of lymph node-derived lymphocytes in human hepatic allografts." Clinical transplants vol. 3 (1989): 316-324.
Fung JJ, Zeevi A, Demetris AJ, Starzl TE, Markus B, Chen K, Marrarri M, Duquesnoy RJ. Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl. 1989;3:316-324. PMID: 23258949; PMCID: PMC3524991.
Copy Download .nbib Format: NLM
Who is a diabetic?.

Canadian family physician Medecin de famille canadien

Reynolds C, Garg AK.
PMID: 21301512
Can Fam Physician. 1978 Jul;24:687-90.

The question 'who is a diabetic?' involves those individuals who present with classical symptoms of diabetes mellitus, those who have no symptoms but glucose intolerance with or without fasting hyperglycemia and those who are sought by investigators searching for...

Cite
Reynolds C, Garg AK. Who is a diabetic?. Can Fam Physician. 1978;24:687-90
Reynolds, C., & Garg, A. K. (1978). Who is a diabetic?. Canadian family physician Medecin de famille canadien, 24687-90.
Reynolds, C, and Garg, A K. "Who is a diabetic?." Canadian family physician Medecin de famille canadien vol. 24 (1978): 687-90.
Reynolds C, Garg AK. Who is a diabetic?. Can Fam Physician. 1978 Jul;24:687-90. PMID: 21301512; PMCID: PMC2379296.
Copy Download .nbib Format: NLM
Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers.

Frontiers in oncology

Su WH, Hildesheim A, Chang YS.
PMID: 24367763
Front Oncol. 2013 Dec 09;3:299. doi: 10.3389/fonc.2013.00299.

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated tumor. In addition to EBV, host genetic factors are believed to be important determinants of NPC risk. Of all genes studies to date, human leukocyte antigen (HLA) genes have shown...

Cite
Su WH, Hildesheim A, Chang YS. Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol. 2013;3:299doi: 10.3389/fonc.2013.00299.
Su, W. H., Hildesheim, A., & Chang, Y. S. (2013). Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Frontiers in oncology, 3299. https://doi.org/10.3389/fonc.2013.00299
Su, Wen-Hui, et al. "Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers." Frontiers in oncology vol. 3 (2013): 299. doi: https://doi.org/10.3389/fonc.2013.00299
Su WH, Hildesheim A, Chang YS. Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers. Front Oncol. 2013 Dec 09;3:299. doi: 10.3389/fonc.2013.00299. PMID: 24367763; PMCID: PMC3856645.
Copy Download .nbib Format: NLM
Human leukocyte antigen variation among Iranian renal transplant recipients.

Journal of nephropathology

Einollahi B, Rostami Z, Teimoori M.
PMID: 24475410
J Nephropathol. 2012 Oct;1(3):164-9. doi: 10.5812/nephropathol.8114. Epub 2012 Oct 01.

BACKGROUND: HLA typing analysis is important in renal transplant patients.OBJECTIVES: We made a plan to determine the most frequent HLA antigens in Iranian kidney transplant patients.PATIENTS AND METHODS: In a retrospective cross sectional study, HLA patterns were defined in...

Cite
Einollahi B, Rostami Z, Teimoori M. Human leukocyte antigen variation among Iranian renal transplant recipients. J Nephropathol. 2012;1(3):164-9doi: 10.5812/nephropathol.8114.
Einollahi, B., Rostami, Z., & Teimoori, M. (2012). Human leukocyte antigen variation among Iranian renal transplant recipients. Journal of nephropathology, 1(3), 164-9. https://doi.org/10.5812/nephropathol.8114
Einollahi, Behzad, et al. "Human leukocyte antigen variation among Iranian renal transplant recipients." Journal of nephropathology vol. 1,3 (2012): 164-9. doi: https://doi.org/10.5812/nephropathol.8114
Einollahi B, Rostami Z, Teimoori M. Human leukocyte antigen variation among Iranian renal transplant recipients. J Nephropathol. 2012 Oct;1(3):164-9. doi: 10.5812/nephropathol.8114. Epub 2012 Oct 01. PMID: 24475410; PMCID: PMC3886157.
Copy Download .nbib Format: NLM
HLA-A, B and DRB1 allele and haplotype frequencies in volunteer bone marrow donors from the north of Parana State.

Revista brasileira de hematologia e hemoterapia

Bardi MS, Jarduli LR, Jorge AJ, Camargo RB, Carneiro FP, Gelinski JR, Silva RA, Lavado EL.
PMID: 23049380
Rev Bras Hematol Hemoter. 2012;34(1):25-30. doi: 10.5581/1516-8484.20120010.

BACKGROUND: Knowledge of allele and haplotype frequencies of the human leukocyte antigen (HLA) system is important in the search for unrelated bone marrow donors. The Brazilian population is very heterogeneous and the HLA system is highly informative of populations...

Cite
Bardi MS, Jarduli LR, Jorge AJ, et al. HLA-A, B and DRB1 allele and haplotype frequencies in volunteer bone marrow donors from the north of Parana State. Rev Bras Hematol Hemoter. 2012;34(1):25-30doi: 10.5581/1516-8484.20120010.
Bardi, M. S., Jarduli, L. R., Jorge, A. J., Camargo, R. B., Carneiro, F. P., Gelinski, J. R., Silva, R. A., & Lavado, E. L. (2012). HLA-A, B and DRB1 allele and haplotype frequencies in volunteer bone marrow donors from the north of Parana State. Revista brasileira de hematologia e hemoterapia, 34(1), 25-30. https://doi.org/10.5581/1516-8484.20120010
Bardi, Marlene Silva, et al. "HLA-A, B and DRB1 allele and haplotype frequencies in volunteer bone marrow donors from the north of Parana State." Revista brasileira de hematologia e hemoterapia vol. 34,1 (2012): 25-30. doi: https://doi.org/10.5581/1516-8484.20120010
Bardi MS, Jarduli LR, Jorge AJ, Camargo RB, Carneiro FP, Gelinski JR, Silva RA, Lavado EL. HLA-A, B and DRB1 allele and haplotype frequencies in volunteer bone marrow donors from the north of Parana State. Rev Bras Hematol Hemoter. 2012;34(1):25-30. doi: 10.5581/1516-8484.20120010. PMID: 23049380; PMCID: PMC3459602.
Copy Download .nbib Format: NLM
Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A.

The Ochsner journal

Vinson AD, Rampolla-Selles R, Cooper ES, Alquist CR.
PMID: 30275791
Ochsner J. 2018;18(3):260-263. doi: 10.31486/toj.17.0068.

BACKGROUND: Acute rejection of lung allografts is an important contributor to morbidity and mortality in the transplant patient population, resulting in the dysfunction and destruction of the graft by the host's immune system via cellular or antibody-mediated mechanisms. Acute...

Cite
Vinson AD, Rampolla-Selles R, Cooper ES, et al. Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A. Ochsner J. 2018;18(3):260-263doi: 10.31486/toj.17.0068.
Vinson, A. D., Rampolla-Selles, R., Cooper, E. S., & Alquist, C. R. (2018). Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A. The Ochsner journal, 18(3), 260-263. https://doi.org/10.31486/toj.17.0068
Vinson, Anthony D, et al. "Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A." The Ochsner journal vol. 18,3 (2018): 260-263. doi: https://doi.org/10.31486/toj.17.0068
Vinson AD, Rampolla-Selles R, Cooper ES, Alquist CR. Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A. Ochsner J. 2018;18(3):260-263. doi: 10.31486/toj.17.0068. PMID: 30275791; PMCID: PMC6162120.
Copy Download .nbib Format: NLM
Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification.

Journal of pathology informatics

Gordon WJ, Ainsworth L, Aronson S, Baronas J, Kaufman RM, Guleria I, Milford EL, Oates M, Paz RD, Yeung MY, Lane WJ.
PMID: 31463162
J Pathol Inform. 2019 Aug 01;10:26. doi: 10.4103/jpi.jpi_29_19. eCollection 2019.

BACKGROUND: Calculated panel reactive antibody (cPRA) scoring is used to assess whether platelet refractoriness is mediated by human leukocyte antigen (HLA) antibodies in the recipient. cPRA testing uses a national sample of US kidney donors to estimate the population...

Cite
Gordon WJ, Ainsworth L, Aronson S, et al. Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification. J Pathol Inform. 2019;10:26doi: 10.4103/jpi.jpi_29_19.
Gordon, W. J., Ainsworth, L., Aronson, S., Baronas, J., Kaufman, R. M., Guleria, I., Milford, E. L., Oates, M., Paz, R. D., Yeung, M. Y., & Lane, W. J. (2019). Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification. Journal of pathology informatics, 1026. https://doi.org/10.4103/jpi.jpi_29_19
Gordon, William J, et al. "Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification." Journal of pathology informatics vol. 10 (2019): 26. doi: https://doi.org/10.4103/jpi.jpi_29_19
Gordon WJ, Ainsworth L, Aronson S, Baronas J, Kaufman RM, Guleria I, Milford EL, Oates M, Paz RD, Yeung MY, Lane WJ. Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification. J Pathol Inform. 2019 Aug 01;10:26. doi: 10.4103/jpi.jpi_29_19. eCollection 2019. PMID: 31463162; PMCID: PMC6686574.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 128 entries